News & Updates

A treatment strategy of targeting a low-density lipoprotein cholesterol (LDL-C) of <70 mg/dL leads to a significant reduction in the composite of adverse cardiovascular (CV) events in patients who have had stroke as compared with an LDL-C target of 100 mg/dL, according to data from the Treat Stroke to Target (TST) trial.

New drug applications approved by US FDA as of 16-30 June 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Progression to cognitive frailty may be predicted by factors including vision, high-density lipoprotein cholesterol (HDL-C) levels, education levels, and participation in cognitively stimulating activities, according to a Singapore study.

Patients with persistent depressive or cognitive symptoms after an acute SARS-CoV-2 infection have elevated gliosis – a secondary event to brain injury – and inflammation as shown in a case-control study.

Undergoing early hysterectomy appears to put women at heightened risk of a composite of cardiovascular disease (CVD), especially stroke, as reported in a study.

An elevated proportion of children and adolescents around the world, particularly girls or those with high BMI, experience disordered eating as shown in a meta-analysis of 32 studies from 16 countries.